Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.770
+0.160 (9.94%)
At close: Nov 6, 2026, 4:00 PM EST
1.790
+0.020 (1.13%)
After-hours: Nov 6, 2026, 7:30 PM EST

Lexicon Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
38.5449.831.081.20.140.3
Revenue Growth
-45.62%60.24%2481.48%766.19%-53.36%-98.76%
Gross Profit
31.8243.2424.63-4.02-52.38-54.75
Operating Income
-56.81-48.91-196.02-171.75-100.46-87.09
Net Income
-62.35-50.34-200.4-177.12-101.94-87.76
Earnings Per Share
-0.15-0.14-0.63-0.80-0.62-0.60
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
183.296.23237.96170.03138.3686.74
Total Debt
51.8962.24106.07106.0655.292.28
Net Cash (Debt)
131.3133.99131.8863.9683.0684.46
Net Cash Growth
157.47%-74.22%106.19%-23.00%-1.66%-39.44%
Net Cash Per Share
0.320.090.410.290.500.58

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--67.85-178.78-161.9-88.85-87.02
Capital Expenditures
---1.03-0.47-1.33-1.22
Free Cash Flow
--67.85-179.81-162.37-90.18-88.24
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
82.57%86.82%79.23%---
Operating Margin
-147.42%-98.21%-630.67%-14264.95%-72273.38%-29224.83%
Pretax Margin
-161.80%-101.08%-644.78%-14710.88%-73341.01%-29448.99%
Profit Margin
-161.80%-101.08%-644.78%-14710.88%-73341.01%-29448.99%
FCF Margin
--136.24%-578.52%-13485.63%-64875.54%-29610.07%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-25.1725.1725.1725.1725.17
PS Ratio
20.558.398.59310.102593.281968.62